Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Momenta Pharma 301 BINNEY STREET CAMBRIDGE MA 02142 USA

www.momentapharma.com P: 617-491-9700

Description:

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and its manufacturing process. They are applying their innovative technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

Key Statistics

Overview:

Market Capitalization, $K 6,246,641
Shares Outstanding, K 119,029
Annual Sales, $ 23,870 K
Annual Net Income, $ -290,060 K
Last Quarter Sales, $ 6,610 K
Last Quarter Net Income, $ -57,030 K
60-Month Beta 1.78
% of Insider Shareholders 3.40%
Float, K 114,982
% Float 96.60%

Growth:

1-Year Return 304.94%
3-Year Return 305.25%
5-Year Return 217.29%
5-Year Revenue Growth -54.32%
5-Year Earnings Growth -58.64%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 10/31/19
Next Earnings Date 10/29/20
Earnings Per Share ttm -2.23
EPS Growth vs. Prev Qtr -41.18%
EPS Growth vs. Prev Year 58.62%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

MNTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -61.44%
Return-on-Assets % -45.28%
Profit Margin % -1,215.17%
Debt/Equity 0.00
Price/Sales 261.77
Price/Cash Flow N/A
Price/Book 15.63
Book Value/Share 3.36
Interest Coverage -142.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar